Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clodronate dosing comparison in postmenopausal osteoporosis
2009-013274-41Phase 3Terminated
- Sponsor
- Società Prodotti Antibiotici
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of clodronate in postmenopausal osteoporosis (3 arms), sponsored by Società Prodotti Antibiotici. Primary endpoint: Lumbar spine bone mineral density. Started Apr 2010; status: terminated.
02
Drugs
clodronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on 2009-013274-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013274-41.